Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$832M |
| 2 |
Johnson & Johnson
JNJ
|
+$706M |
| 3 |
Datadog
DDOG
|
+$549M |
| 4 |
Amazon
AMZN
|
+$442M |
| 5 |
Eli Lilly
LLY
|
+$372M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Workday
WDAY
|
+$1.22B |
| 2 |
AbbVie
ABBV
|
+$1.07B |
| 3 |
Advanced Micro Devices
AMD
|
+$817M |
| 4 |
Amgen
AMGN
|
+$706M |
| 5 |
Honeywell
HON
|
+$659M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.69% |
| 2 | Healthcare | 17.58% |
| 3 | Consumer Discretionary | 10.69% |
| 4 | Financials | 10.23% |
| 5 | Communication Services | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Unilever
UL
$141B
| $1.01M | ﹤0.01% |
15,820
-1,971
| -11% | -$133K |
|
|
PINC
1677
DELISTED
Premier
PINC
| $1.01M | ﹤0.01% |
47,435
-5,300
| -10% | -$112K |
|
1678
Banner Corp
BANR
$2.37B
| $1M | ﹤0.01% |
15,072
| – | – |
|
1679
Clearway Energy Class C
CWEN
$4.94B
| $1M | ﹤0.01% |
38,562
| – | – |
|
|
CTNM
1680
Contineum Therapeutics
CTNM
$589M
| $1M | ﹤0.01% |
+68,320
| New | +$1.08M |
|
|
HI
1681
DELISTED
Hillenbrand
HI
| $1,000K | ﹤0.01% |
32,470
| – | – |
|
1682
Pricesmart
PSMT
$5.94B
| $996K | ﹤0.01% |
10,813
+1,400
| +15% | +$128K |
|
1683
MGM Resorts International
MGM
$11.7B
| $993K | ﹤0.01% |
28,649
-12,552
| -30% | -$474K |
|
1684
Warby Parker
WRBY
$3.19B
| $990K | ﹤0.01% |
40,894
| – | – |
|
1685
CONMED
CNMD
$1.41B
| $989K | ﹤0.01% |
14,459
| – | – |
|
1686
Lemonade
LMND
$3.76B
| $986K | ﹤0.01% |
26,851
| – | – |
|
|
CURB
1687
Curbline Properties
CURB
$3.52B
| $984K | ﹤0.01% |
+42,354
| New | +$996K |
|
1688
ICF International
ICFI
$1.46B
| $981K | ﹤0.01% |
8,229
| – | – |
|
1689
XPEL
XPEL
$1.22B
| $979K | ﹤0.01% |
24,501
+2,054
| +9% | +$87.7K |
|
1690
Crescent Energy
CRGY
$3.69B
| $977K | ﹤0.01% |
66,857
+19,500
| +41% | +$265K |
|
1691
Alaska Air
ALK
$5.27B
| $977K | ﹤0.01% |
15,088
| – | – |
|
|
SWTX
1692
DELISTED
SpringWorks Therapeutics
SWTX
| $977K | ﹤0.01% |
27,025
| – | – |
|
1693
Cheesecake Factory
CAKE
$5.03B
| $975K | ﹤0.01% |
20,562
+2,600
| +14% | +$120K |
|
|
SEZL
1694
Sezzle
SEZL
$5.22B
| $973K | ﹤0.01% |
22,812
+6,900
| +43% | +$326K |
|
|
OPLN
1695
Openlane
OPLN
$4.29B
| $973K | ﹤0.01% |
49,060
+6,100
| +14% | +$113K |
|
1696
Liberty Global Class A
LBTYA
$3.56B
| $971K | ﹤0.01% |
76,000
| – | – |
|
1697
Celanese
CE
$4.91B
| $971K | ﹤0.01% |
14,024
+251
| +2% | +$24.1K |
|
1698
Oscar Health
OSCR
$9.42B
| $970K | ﹤0.01% |
72,236
| – | – |
|
1699
Acadia Pharmaceuticals
ACAD
$4.55B
| $970K | ﹤0.01% |
52,824
| – | – |
|
1700
Nu Holdings
NU
$70B
| $968K | ﹤0.01% |
93,428
-2,495
| -3% | -$33.2K |
|
Similar funds
Janus Henderson Group's Q4 2024 Portfolio in Review
As of Q4 2024, Janus Henderson Group held 2,620 positions worth $197B, up 0.7% from $195B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Janus Henderson Group's Q4 2024 filing shows 92 new, 801 increased, 713 reduced and 96 closed positions. Its largest new stake was Lam Research: 10,967,975 shares worth $792M. The largest sale was Workday, an estimated $1.22B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 34% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q4 2024 buy was Lam Research: 10,967,975 shares worth $792M.
- Janus Henderson Group added most to Johnson & Johnson in Q4 2024, an estimated $706M increase.
- Janus Henderson Group's biggest Q4 2024 reduction was Workday, cutting an estimated $1.22B.
- Janus Henderson Group fully exited Coca-Cola Europacific Partners in Q4 2024, selling an estimated $52.4M.
- Janus Henderson Group's ten largest holdings make up 32% of its $197B portfolio in Q4 2024.
- Janus Henderson Group opened 92 new positions and closed 96 in Q4 2024.
- Janus Henderson Group's portfolio value rose 0.7% quarter-over-quarter to $197B.
Based on Janus Henderson Group's 13F filing for Q4 2024, filed 14 Feb 2025.